Literature DB >> 6723655

Primary structures of the alpha-crystallin A chains of twenty-eight mammalian species, chicken and frog.

W W de Jong, A Zweers, M Versteeg, E C Nuy-Terwindt.   

Abstract

The amino acid sequences of the alpha-crystallin A chains of 28 mammalian species, representing 14 different orders, have been analyzed, mainly on the basis of amino acid compositions of the composing peptides. The alpha A sequences of chicken and a frog have been completely determined by Edman degradation. A method is described to transport eye lenses, to be used for protein sequence studies, at ambient temperature in a solution of guanidine . HCl. The number of cysteine residues in different alpha A chains could be determined by alkaline urea gel electrophoresis after aminoethylation . In some cases the alpha A chains have been isolated from total lens extracts in a single ion-exchange chromatographic step. The average rate of substitutions in the evolution of the alpha A chains is moderately slow, approximately 3 amino acid substitutions per 100 residues in 100 million years, but varies considerably in different lineages. Substitutions involving changes in charge are strongly underrepresented; the alpha A chains tend to keep their net charge constant throughout evolution. Analysis of the types of substitutions suggests a directional trend leading to an increase in functional density of alpha A in the course of evolution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723655     DOI: 10.1111/j.1432-1033.1984.tb08167.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Phylogeny of the alpha-crystallin-related heat-shock proteins.

Authors:  N Plesofsky-Vig; J Vig; R Brambl
Journal:  J Mol Evol       Date:  1992-12       Impact factor: 2.395

2.  Differential binding of mutant (R116C) and wildtype alphaA crystallin to actin.

Authors:  Zachery Brown; Aldo Ponce; Kirsten Lampi; Lynn Hancock; Larry Takemoto
Journal:  Curr Eye Res       Date:  2007-12       Impact factor: 2.424

3.  Episodic evolution in the stomach lysozymes of ruminants.

Authors:  J Jollès; P Jollès; B H Bowman; E M Prager; C B Stewart; A C Wilson
Journal:  J Mol Evol       Date:  1989-06       Impact factor: 2.395

4.  A novel alphaB-crystallin mutation associated with autosomal dominant congenital lamellar cataract.

Authors:  Yizhi Liu; Xinyu Zhang; Lixia Luo; Mingxing Wu; Ruiping Zeng; Gang Cheng; Bin Hu; Bingfen Liu; Jack J Liang; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  The expanding small heat-shock protein family, and structure predictions of the conserved "alpha-crystallin domain".

Authors:  G J Caspers; J A Leunissen; W W de Jong
Journal:  J Mol Evol       Date:  1995-03       Impact factor: 2.395

6.  The lack of chaperonelike activity of Caenorhabditis elegans Hsp12.2 cannot be restored by domain swapping with human alphaB-crystallin.

Authors:  B P Kokke; W C Boelens; W W de Jong
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

7.  Sequence and spatial expression of zebrafish (Danio rerio) alphaA-crystallin.

Authors:  Stephanie Runkle; Julie Hill; Marc Kantorow; Joseph Horwitz; Mason Posner
Journal:  Mol Vis       Date:  2002-03-11       Impact factor: 2.367

8.  A reassessment of mammalian alpha A-crystallin sequences using DNA sequencing: implications for anthropoid affinities of tarsier.

Authors:  C J Jaworski
Journal:  J Mol Evol       Date:  1995-12       Impact factor: 2.395

9.  Characterization of anti-crystallin autoantibodies in patients with cataract.

Authors:  K B Merck; W A de Haard-Hoekman; J R Cruysberg; H Bloemendal; W W de Jong
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

10.  Comparison of the homologous carboxy-terminal domain and tail of alpha-crystallin and small heat shock protein.

Authors:  K B Merck; J Horwitz; M Kersten; P Overkamp; M Gaestel; H Bloemendal; W W de Jong
Journal:  Mol Biol Rep       Date:  1993-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.